PRE 14A

PRE 14A 2016

Company: LISATA THERAPEUTICS, INC.
Filed: April 29, 2016
Period of Report: April 29, 2016
Accession Number: 0000320017-16-000112

View Document ↗ View on SEC.gov ↗